Skip to main content

ADVERTISEMENT

outcomes research

Research in Review
11/23/2016
JCP Editors
Hybrid capture (HC)-based next-generation sequencing (NGS) can identify targetable oncogenic drivers to improve response rates in patients with lung cancer, according to a study published in the Journal of Thoracic...
Hybrid capture (HC)-based next-generation sequencing (NGS) can identify targetable oncogenic drivers to improve response rates in patients with lung cancer, according to a study published in the Journal of Thoracic...
Hybrid...
11/23/2016
Journal of Clinical Pathways
Research in Review
11/22/2016
JCP Editors
First-line therapy with cabozantinib was superior to standard of care sunitinib with respect to progression-free survival and objective response rate for patients with intermediate- or poor-risk metastatic renal cell...
First-line therapy with cabozantinib was superior to standard of care sunitinib with respect to progression-free survival and objective response rate for patients with intermediate- or poor-risk metastatic renal cell...
...
11/22/2016
Journal of Clinical Pathways
Research in Review
11/21/2016
JCP Editors
Patients with non-small cell lung cancer (NSCLC) may see improved survival predictions as a result of a new prognostic tool that includes EGFR and ALK gene alterations data, according to an analysis published...
Patients with non-small cell lung cancer (NSCLC) may see improved survival predictions as a result of a new prognostic tool that includes EGFR and ALK gene alterations data, according to an analysis published...
...
11/21/2016
Journal of Clinical Pathways
Research in Review
11/17/2016
JCP Editors
Using mathematical modeling, researchers have determined the best combination and sequencing of targeted therapies for the treatment of chronic myeloid leukemia (CML). Their results have been published in PLOS...
Using mathematical modeling, researchers have determined the best combination and sequencing of targeted therapies for the treatment of chronic myeloid leukemia (CML). Their results have been published in PLOS...
Using...
11/17/2016
Journal of Clinical Pathways
Research in Review
11/17/2016
JCP Editors
Single-agent blinatumomab demonstrated antileukemia activity in pediatric patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL), according to a study published in the Journal of...
Single-agent blinatumomab demonstrated antileukemia activity in pediatric patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL), according to a study published in the Journal of...
...
11/17/2016
Journal of Clinical Pathways
Research in Review
11/15/2016
JCP Editors
A pediatric stroke clinical pathway significantly improved time to definitive diagnosis while also streamlining the care provided to children presenting to the pediatric emergency department (ED) with focal...
A pediatric stroke clinical pathway significantly improved time to definitive diagnosis while also streamlining the care provided to children presenting to the pediatric emergency department (ED) with focal...
A...
11/15/2016
Journal of Clinical Pathways
Research in Review
11/15/2016
JCP Editors
Targeted therapies have been shown to significantly improve the survival of patients with human epidermal growth factor 2 (HER2)-positive metastatic breast cancer. However, these therapies have also been associated...
Targeted therapies have been shown to significantly improve the survival of patients with human epidermal growth factor 2 (HER2)-positive metastatic breast cancer. However, these therapies have also been associated...
...
11/15/2016
Journal of Clinical Pathways
Research in Review
11/11/2016
JCP Editors
Kaposi Sarcoma (KS) skin lesions are more likely to respond to local external beam radiotherapy than repeat radiotherapy, according to a study conducted by members of the Department of Radiation Oncology, University...
Kaposi Sarcoma (KS) skin lesions are more likely to respond to local external beam radiotherapy than repeat radiotherapy, according to a study conducted by members of the Department of Radiation Oncology, University...
Kaposi...
11/11/2016
Journal of Clinical Pathways
Research in Review
11/11/2016
JCP Editors
Neoadjuvant endocrine therapy may be just as effective as neoadjuvant chemotherapy for patients with localized, estrogen-receptor (ER)-positive breast cancer with considerably fewer adverse events, according to a...
Neoadjuvant endocrine therapy may be just as effective as neoadjuvant chemotherapy for patients with localized, estrogen-receptor (ER)-positive breast cancer with considerably fewer adverse events, according to a...
...
11/11/2016
Journal of Clinical Pathways
Quiz
11/10/2016
JCP Editors
A study published in JAMA Oncology recently showed that treatment with which of the following drug types was just as effective as BRAF- and MEK-targeted therapies for melanoma and also limited the risk of...
A study published in JAMA Oncology recently showed that treatment with which of the following drug types was just as effective as BRAF- and MEK-targeted therapies for melanoma and also limited the risk of...
A...
11/10/2016
Journal of Clinical Pathways